DRKS00026602已完成4 期
Investigation to assess the efficacy of benzyl benzoate 10/25% emulsion versus oral ivermectin for scabies treatment
niversitätsklinik für Dermatologie, Paracelsus Medizinische Universität Salzburg (PMU)0 个研究点目标入组 224 人开始时间: 2021年9月7日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 224
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 1 Years 至 99 Years（—）
- 性别
- All
入选标准
- •diagnosis of scabies (dermatoscopically confirmed)
排除标准
- •Scabies crutosa
- •- pre-treatment with topical Benzyl Benzoate XML File Identifier: bekvJUBdLZKFbixLby3v6TN1L5w=
- •- use of topical Permethrin (e.g. Infectoscab 5% Creme®) within the last 2 weeks (child <6 years) or 3 weeks (age = 6years)
- •- sufficient use of oral ivermectin within the last 3 months
- •- allergy or intolerance agains top. benzyl benzoate Emulsion
- •- mental disfunction
- •- pregnancy/breast-feeding
- •- alcohol abuse
研究者
相似试验
进行中（未招募）
1 期
Investigation to assess the efficacy of benzyl benzoate 10/25% emulsion versus oral ivermectin for scabies treatmentScabiesEUCTR2020-003255-15-ATandeskrankenhaus Salzburg200
招募中
4 期
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis for Facial ContouringHealthy patientBipolar Radiofrequency-Assisted Lipolysis, Facial ContouringTCTR20230516008ASTRACO MEDICAL NETWORKS LTD.39
招募中
4 期
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis for cheek and nasolabial fold ContouringHealthy patientBipolar Radiofrequency-Assisted Lipolysis, Cheek and nasolabial fold ContouringTCTR20230515001ASTRACO MEDICAL NETWORKS LTD.39
招募中
4 期
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis combined with Adjustable-depth fractional microneedle bipolar radiofrequency for periorbital RejuvenatioHealthy PatientBipolar Radiofrequency-Assisted Lipolysis,Adjustable-depth fractional microneedle bipolar radiofrequency,periorbital RejuvenationTCTR20230417001ASTRACO MEDICAL NETWORKS LTD.38
已完成
不适用
A pilot study for the efficacy of the non-benzodiazepine hypnotic or orexin receptor antagonist on insomnia in major depressive patients unresponsive to benzodiazepine hypnotic treatment: a randomized open-label trial.major depressive disorderJPRN-UMIN000031032Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital40